Skip to main content
. 2020 Oct 8;12(4):449–456. doi: 10.4103/jpbs.JPBS_294_19

Table 3.

Susceptibility pattern of Enterococcus faecalis

Antibiotics Test done (td) Resistant, N (%) 95% CI resistant Sensitive, N (%) 95% CI, sensitive Test not done (nd)
Penicillin 4 4 (100.00) 51.01–100 0 (0) 0 23
Ampicillin 28 13 (46.43) 29.53–64.19 15 (53.57) 35.81–70.47 7
Augmentin 4 3 (75.00) 30.06–95.44 1 (25.00) 4.56–69.94 34
Oxacillin 3 3 (100.00) 43.85–100 0 (0) 0 31
Imipenem 8 7 (87.50) 52.91–97.76 1 (12.50) 2.24–47.09 25
Meropenem 1 1 (100.00) 20.65–100 0 (0) 0 38
Cephalexin 4 4 (100.00) 51.01–100 0.00 0 30
Cefoxitin 15 14 (93.33) 70.18–98.81 1 (6.67) 1.19–29.82 23
Gentamicin 22 16 (72.73) 51.85–86.85 6 (27.27) 13.15–48.15 16
Ciprofloxacin 12 8 (66.67) 39.06–86.19 4 (33.33) 13.81–60.94 26
Norfloxacin 1 1 (100.00) 20.65–100 0 (0) 0 37
Erythromycin 26 23 (88.46) 71.02–96.00 3 (11.54) 4.0–28.98 12
Tetracycline 4 3 (75.00) 30.06–95.44 1 (25.00) 4.56–69.94 27
Doxycycline 2 1 (50.00) 9.45–90.55 1 (50.00) 9.45–90.55 28
Clindamycin 15 14 (93.33) 70.18–98.81 1 (6.67) 1.19–29.82 23
Vancomycin 29 0 (0) 0 29 (100.00) 88.30–100 9
Linezolid 22 0 (0) 0 22 (100.00) 85.13–100 16
Tigecycline 4 0 (0) 0 4 (100.00) 51.01–100 40
Colistin 1 0 (0) 0 1 (100.00) 20.65–100 33
Nitrofurantoin 24 4 (16.67) 6.68–35.85 20 (83.33) 64.15–93.32 14
TMP-SMX 19 9 (47.37) 27.33–68.29 10 (52.63) 31.71–72.67 19
Teicoplanin 13 0 (0) 0 13 (100.00) 77.19–100 18

N = frequency, CI = confidence interval, TMP-SMX = Trimethoprim and sulfamethoxazole, td = respective antibiotic tested against E. faecalis, nd = respective antibiotic was not tested against E. faecalis